Actinium Pharmaceuticals
ATNM
ATNM
66 hedge funds and large institutions have $52.8M invested in Actinium Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.92% more ownership
Funds ownership: 21.37% → 24.29% (+2.9%)
0% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 18
Holders
66
Holding in Top 10
–
Calls
$3.23M
Puts
$1.3M
Top Buyers
| 1 | +$1.54M | |
| 2 | +$1.19M | |
| 3 | +$783K | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$730K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$643K |
Top Sellers
| 1 | -$1.01M | |
| 2 | -$371K | |
| 3 | -$144K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$82K |
| 5 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$72.6K |